Thiamyxins: Structure and Biosynthesis of Myxobacterial RNA-Virus Inhibitors
- PMID: 36208117
- PMCID: PMC10100342
- DOI: 10.1002/anie.202212946
Thiamyxins: Structure and Biosynthesis of Myxobacterial RNA-Virus Inhibitors
Abstract
During our search for novel myxobacterial natural products, we discovered the thiamyxins: thiazole- and thiazoline-rich non-ribosomal peptide-polyketide hybrids with potent antiviral activity. We isolated four congeners of this unprecedented natural product family with the non-cyclized thiamyxin D fused to a glycerol unit at the C-terminus. Alongside their structure elucidation, we present a concise biosynthesis model based on biosynthetic gene cluster analysis and isotopically labelled precursor feeding. We report incorporation of a 2-(hydroxymethyl)-4-methylpent-3-enoic acid moiety by a GCN5-related N-acetyltransferase-like decarboxylase domain featuring polyketide synthase. The thiamyxins show potent inhibition of RNA viruses in cell culture models of corona, zika and dengue virus infection. Their potency up to a half maximal inhibitory concentration of 560 nM combined with milder cytotoxic effects on human cell lines indicate the potential for further development of the thiamyxins.
Keywords: Antiviral Agents; Biosynthesis; Depsipeptides; Natural Products; Structure Elucidation.
© 2022 The Authors. Angewandte Chemie International Edition published by Wiley-VCH GmbH.
Conflict of interest statement
The authors declare no conflict of interest.
Figures




References
-
- None
-
- “WHO Coronavirus Disease (COVID-19) Dashboard|WHO Coronavirus Disease (COVID-19) Dashboard”, to be found under https://covid19.who.int/, 2020;
-
- None
-
- Ireland C. M., Durso A. R., Newman R. A., Hacker M. P., J. Org. Chem. 1982, 47, 1807–1811;
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical